-
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Rochester, MN
The purpose of this study is to evaluate the efficacy of GSK Biologicals' vaccine GSK1437173A in the prevention of Herpes zoster (HZ) in autologous haematopoietic cell transplant recipients 18 years of age and older. To this end, the study will evaluate vaccine efficacy (VE) of the GSK1437173A vaccine, administered on a 2-dose schedule, compared to placebo in reducing the risk of developing HZ in this population.
-
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A: Unblinding Communication
Rochester, MN
The purpose of this study is to share treatment information with patients participating in “Observer-blind study to evaluate efficacy, safety, and immunogenicity of GSK Biologicals' Herpes Zoster vaccine GSK1437173A”. We’d like to inform the patients of which treatment they receive while on this study so they are able to make better informed health care decisions in the future.
-
Study to Assess the Safety and Effectiveness of Shingrix Vaccine in Patients with Hematologic Malignancies
Rochester, MN
The purpose of this study is to compare the response of Shingrix vaccination among patients with untreated MBL and low-risk CLL to patients with untreated intermediate and high-risk CLL.